TVARDI THERAPEUTICS, INC. Debt Securities, Available-for-sale, Realized Gain (Loss)
TVARDI THERAPEUTICS, INC. (TVRD) reported Debt Securities, Available-for-sale, Realized Gain (Loss) of $39.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2024-03-06.
Discontinued › Income Statement › Other Income
us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss · last filed 2024-03-06
- TVARDI THERAPEUTICS, INC. debt securities, available-for-sale, realized gain (loss) for the quarter ending 2021-12-31 was $0.00, a 100.00% decline year-over-year.
- TVARDI THERAPEUTICS, INC. debt securities, available-for-sale, realized gain (loss) for the quarter ending 2021-09-30 was $0.00, a 100.00% decline year-over-year.
- TVARDI THERAPEUTICS, INC. debt securities, available-for-sale, realized gain (loss) for the quarter ending 2021-06-30 was $0.00, a 100.00% decline year-over-year.
- TVARDI THERAPEUTICS, INC. debt securities, available-for-sale, realized gain (loss) for the quarter ending 2021-03-31 was $39.00K.
- TVARDI THERAPEUTICS, INC. debt securities, available-for-sale, realized gain (loss) for fiscal 2021 was $39.00K, a 85.66% decline from fiscal 2020.
- TVARDI THERAPEUTICS, INC. debt securities, available-for-sale, realized gain (loss) for fiscal 2020 was $272.00K.
- TVARDI THERAPEUTICS, INC. debt securities, available-for-sale, realized gain (loss) for fiscal 2018 was -$5.00K, a 200.00% decline from fiscal 2017.
- TVARDI THERAPEUTICS, INC. debt securities, available-for-sale, realized gain (loss) for fiscal 2017 was $5.00K, a 78.26% decline from fiscal 2016.
| Period end | Debt Securities, Available-for-sale, Realized Gain (Loss) 3 month | Debt Securities, Available-for-sale, Realized Gain (Loss) 6 month | Debt Securities, Available-for-sale, Realized Gain (Loss) 9 month | Debt Securities, Available-for-sale, Realized Gain (Loss) 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-06 | $0.00 derived: sum of 2 quarters · filed 2024-03-06 | $0.00 derived: sum of 3 quarters · filed 2024-03-06 | $39.00K 10-K · filed 2024-03-06 |
| 2021-09-30 | $0.00 10-Q · filed 2022-11-07 | $0.00 derived: sum of 2 quarters · filed 2022-11-07 | $39.00K 10-Q · filed 2022-11-07 | $185.00K derived: sum of 4 quarters · filed 2023-03-06 |
| 2021-06-30 | $0.00 10-Q · filed 2022-08-08 | $39.00K 10-Q · filed 2022-08-08 | $185.00K derived: sum of 3 quarters · filed 2023-03-06 | $251.00K derived: sum of 4 quarters · filed 2023-03-06 |
| 2021-03-31 | $39.00K 10-Q · filed 2022-05-09 | $185.00K derived: sum of 2 quarters · filed 2023-03-06 | $251.00K derived: sum of 3 quarters · filed 2023-03-06 | $311.00K derived: sum of 4 quarters · filed 2023-03-06 |
| 2020-12-31 | $146.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $212.00K derived: sum of 2 quarters · filed 2023-03-06 | $272.00K derived: sum of 3 quarters · filed 2023-03-06 | $272.00K 10-K · filed 2023-03-06 |
| 2020-09-30 | $66.00K 10-Q · filed 2021-11-08 | $126.00K derived: sum of 2 quarters · filed 2021-11-08 | $126.00K 10-Q · filed 2021-11-08 | |
| 2020-06-30 | $60.00K 10-Q · filed 2021-08-09 | $60.00K 10-Q · filed 2021-08-09 | ||
| 2018-12-31 | $27.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $10.00K derived: sum of 2 quarters · filed 2021-02-25 | $10.00K derived: sum of 3 quarters · filed 2021-02-25 | -$5.00K 10-K · filed 2021-02-25 |
| 2018-09-30 | -$17.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | -$17.00K derived: sum of 2 quarters · filed 2019-11-05 | -$32.00K 10-Q · filed 2019-11-05 | -$31.00K derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | -$15.00K 10-Q · filed 2019-08-07 | -$14.00K derived: sum of 3 quarters · filed 2020-02-27 | |
| 2018-03-31 | -$15.00K 10-Q · filed 2019-05-07 | -$14.00K derived: sum of 2 quarters · filed 2020-02-27 | ||
| 2017-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $5.00K 10-K · filed 2020-02-27 | ||
| 2017-09-30 | $4.00K 10-Q · filed 2018-11-06 | |||
| 2016-12-31 | $23.00K 10-K · filed 2019-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |